Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling

Molecular and Cellular Biology

Volumn 23, Issue 13, 2003, Pages 4649-4662

  Sanchez, Joseph F ^a   Sniderhan, Lynn F ^a   Williamson, Andrea L ^a   Fan, Shongshan ^a   Chakraborty Sett, Shikha ^a   Maggirwar, Sanjay B ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL SURVIVAL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ANIMALS; APOPTOSIS; ASTROCYTES; CELLS, CULTURED; CYCLOOXYGENASE 2; DNA; DNA, COMPLEMENTARY; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; GLYCOGEN SYNTHASE KINASE 3; I-KAPPA B KINASE; IMMUNOBLOTTING; IN SITU NICK-END LABELING; ISOENZYMES; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NF-KAPPA B; PRECIPITIN TESTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0038044650     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.13.4649-4662.2003     Document Type: Article

References (88)

1. Ahhott, K. L., A. M. Rohida, M. E. Davis, G. K. Pavlath, J. M. Camden, J. T. Turner, and T. J. Murphy. 2000. Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors. J. Mol. Cell. Cardiol. 32:391-403.
2. Allport, V. C., D. M. Slater, R. Newton, and P. R. Bennett. 2000. NF-κ and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod. 6:561-565.
3. Barbin, G., M. P. Roisin, and B. Zalc. 2001. Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem. Res. 26:107-112.
4. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crahtree. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-1934.
5. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κ in preventing TNF-alpha-induced cell death. Science 274:782-784.
6. Bertrand, F., A. Atfi, A. Cadoret, G. L'Allemain, H. Robin, O. Lascols, J. Capeau, and G. Cherqui. 1998. A role for nuclear factor κB in the antiapoptotic function of insulin. J. Biol. Chem. 273:2931-2938.
7. Bezzi, P., M. Domercq, L. Bramhilla, R. Galli, D. Schols, E. De Clercq, A. Veseovi, G. Bagetta, G. Kolllas, J. Meldolesi, and A. Volterra. 2001 CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4:702-710.
8. Bezzl, P., M. Domercq, S. Vesce, and A. Volterra. 2001. Neoron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog. Brain. Res. 132:255-265.
9. Bijur, G. N., P. De Sarno, and R. S. Jope. 2000. Glycogen synthase kinase-3β facililates staurosporine- and heal shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 275:7583-7590.
10. Bournat, J. C., A. M. Brown, and A. P. Soler. 2000. Wnt-1 dependent activation of the survival factor NF-κB in PC12 cells. J. Neurosci. Res. 61:21-32.
11. Boyle, W. J., T. Smeal, L. H. Defize, P. Angel, J. R. Woodgett, M. Karin, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584.
12. Bramhilia, R., and M. P. Ahhracchlo. 2001. Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. N. Y. Acad. Sci. 939:54-62.
13. Caivano, M., B. Gorgoni, P. Cohen, and V. Poli. 2001. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-hinding protein beta (C/EBP beta) and C/EBP delta transcription factors. J. Biol. Chem. 276:48693-48701.
14. Carbott, D. E., L. Duan, and M. A. Davis. 2002. Phosphoinositol 3 kinase inhibitor, LY294002 increases bcl-2 protein and inhibits okadaic acid-induced apoptosis in Bcl-2 expressing renal epithelial cells. Apoptosis 7:69-76.
15. Chen, G., L. D. Huang, Y. M. Jiang, and H. K. Manji. 1999. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72:1327-1330.
16. Cross, D. A., A. A. Culbert, K. A. Chalmers, L. Facci, S. D. Skaper, and A. D. Reith. 2001. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77:94-102.
17. Crowder, R. J., and R. S. Freeman. 2000. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J. Biol. Chem. 275:34266-34271.
18. Deininger, M. H., R. Meyermann, K. Trautmann, M. Morgalla, F. Duffner, E. H. Grote, J. Wickboldt, and H. J. Schluesener. 2000. Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res. 885:111-116.
19. Di Iorio, S. Kleywegt, R. Ciccarelli, U. Traversa, C. M. Andrew C. E. Crocker, E. S. Werstiuk and M. P. Rathbone. 2002. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38:179-190.
20. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
21. Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511.
22. Emhi, N., D. B. Rylatt, and P. Cohen. 1980. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107:519-527.
23. Foehr, E. D., J. Bohuslav, L. F. Chen, C. DeNoronha, R. Geleziunas, X. Lin, A. O'Mahony, and W. C. Greene. 2000. The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis. J. Biol. Chem. 275:34021-34024.
24. Frame, S., P. Cohen, and R. M. Biondi. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7:1321-1327.
25. Fraser, E., N. Young, R. Dajani, J. Franca-Koh, J. Ryves, R. S. Williams, M. Yeo, M. T. Webster, C. Richardson, M. J. Smalley, L. H. Pearl, A. Harwood, and T. C. Dale. 2002. Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J. Biol. Chem. 277:2176-2185.
26. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-S96.
27. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
28. Ginger, R. S., E. C. Dalton, W. J. Ryves, M. Fukuzawa, J. G. Williams, and A. J. Harwood. 2000. Glycogen synthase kinase-3 enhances nuclear export of a Dictyostelium STAT protein. EMBO J. 19:5483-5491.
29. Grimes, C. A., and R. S. Jope. 2001. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J. Neurochem. 78:1219-1232.
30. Grimes, C. A., and R. S. Jope. 2001. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65:391-426.
31. Hazell, A. S. 2002. Astrocytes and manganese neurotoxicity. Neurochem. Int. 41:271-277.
32. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
33. Hetman, M., J. E. Cavanaugh, D. Kimelman, and Z. Xia. 2000. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20:2567-2574.
34. Hoeflich, K. P., J. Luo, E. A. Rubie, M. S. Tsao, O. Jin, and J. R. Woodgett. 2000. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406:86-90.
35. Hostettler, M. E., P. E. Knapp, and S. L. Carlson. 2002. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. Glia 38:228-239.
36. Hu, Y. V. Baud, M. Delhase, P. Zhang, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKκ subunit of IκB kinase. Science 284:316-320.
37. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
38. Kaul, M., G. A. Garden, and S. A. Lipton. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
39. Kawamura, N., L. Singer, R. A. Wetsel, and H. R. Colten. 1992. Cis- and trans-acting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene. Biochem. J. 283:705-712.
40. Kim, M. S. Y., P. Cheong, H. S. So, K. M. Lee, T. Y. Kim, J. Oh, Y. T. Chung, Y. Son, B. R. Kim, and R. Park. 2001. Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem. Pharmacol. 61:779-786.
41. Leclerc, S., M. Garnier, R. Hoessel, D. Marko, J. A. Bibb, G. L. Snyder, P. Greengard, J. Biernat, Y. Z. Wu, E. M. Mandelkow G. Eisenhrand, and L. Meijer. 2001. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276:251-260.
42. Lezoualc'h, F. Y. Sagara, F. Holsboer, and C. Behl. 1998. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18:3224-3232.
43. Li, M., X. Wang, M. K. Meintzer, T. Laessig, M. J. Birnbaum, and K. A. Heidenreich. 2000. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β. Mol. Cell. Biol. 20:9356-9363.
44. Li, Q., Q. Lu, J. Y. Hwang, D. Buscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
45. Li, Z. W., W. Chu, Y. Hu, M. Delhase, T. Deerinck M. Ellisman, R. Johnson, and M. Karin. 1999. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.
46. Maggirwar, S. B., S. Ramirez, N. Tong, H. A. Gelbard, and S. Dewhurst. 2000. Functional interplay between nuclear factor-κB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factor-dependent PC12 cells. J. Neurochem. 74:527-539.
47. Maggirwar, S. B., N. Tong, S. Ramirez, H. A. Gelbard, and S. Dewhurst. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3κ contributes to Tat-mediated neurotoxicity. J. Neurochem. 73:578-586.
48. Makais, C., V. L. Godfrey, G. Krahn-Senftleben, T. Takahashi, J. L. Roberts, T. Schwarz, L. Feng, R. S. Johnson and M. Karin. 2000. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dematopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5:969-979.
49. Mattson, M. P. 2000. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell. Biol. 1:120-129.
50. May, M. J., F. D'Acquisto L. A. Madge, J. Glockner, J. S. Pober, and S. Ghosh. 2000. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289:1550-1554.
51. Moule, S. K., G. I. Welsh, N. J. Edgell, E. J. Foulstone, C. G. Proud, and R. M. Denton. 1997. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272:7713-7719.
52. Naked, S., Y. Ogala, E. Shimizu-Sasaki, M. Yamazaki, S. Furuyama, and H. Sngiya. 2000. Activation of NFκB is necessary for IL-1β-induced cyclooxygenase-2 (COX-2) expression in human gingival fibrobtasts. Mol. Cell. Biochem. 209:113-118.
53. Nedergaard, M. 1994. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263:1768-1771.
54. O'Connell, M. A., B. L. Bennett, F. Mercurio, A. M. Manning, and N. Mackman. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 273:30410-30414.
55. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
56. Pap, M., and G. M. Cooper. 1998. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273:19929-19932.
57. Pap, M., and G. M. Cooper. Co,pen 2002. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway. Mol. Cell. Biol. 22:578-586.
58. Parpura, V., T. A. Basarsky, F. Liu, K. Jeftinija, S. Jeftinija and P. G. Haydon. 1994. Glutamate-mediated astrocyte-neuron signalling. Nature 369:744-747.
59. Pfrieger, F. W., and B. A. Barres. 1997. Synaptic efficacy enhanced by glial cells in vitro. Science 277:1684-1687.
60. Ramirez, S. H., J. F. Sanchez, C. A. Dimitri, H. A. Gelbard, S. Dewhurst, and S. B. Maggiman. 2001. Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-κB (NF-κB)-dependent mechanism. J. Neurochem. 78:874-889.
61. Reuther, J. Y., and A. S. Baldwin, Jr. 1999. Apoptosis promotes a caspase-induced amino-terminal truncation of IκBα that functions as a stable inhib-itor of NF-κB. J. Biol. Chem. 274:20664-20670.
62. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-gamma is an essential regulatory subunit of the IκB kinase complex. Nature 395:297-300.
63. Rudolph, D., W. C. Yeh, A. Wakeham, B. Rudolph, D. Nallainthan, J. Potter, A. J. Ella, and T. W. Mak. 2000. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14:854-862.
64. Saas, P., J. Boucraut, A. L. Qulquerez, V. Schnuriger, G. Perrin, S. Desplat-Jego, D. Bernard, P. R. Walker, and P. Y. Dietrich. 1999. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses esponses: a key role in brain inflammation? J. Immunol. 162:2326-2333.
65. Schouten, G. J., A. C. Vertegaal, S. T. Whiteside, A. Israel, M. Toebes, J. C. Dorsman, A. J. van der Eb, and A. Zantema. 1997. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:3133-3144.
66. Schwabe, R. F., and D. A. Brenner. 2002. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-κB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G204-G211.
67. Song, H., C. F. Stevens, and F. H. Gage. 2002. Astroglia induce neurogenesis from adult neural stem cell. Nature 417:39-44.
68. Taheda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313-316.
69. Tamatani, M., Y. H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno, and M. Tohyama. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538.
70. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L. Hardy, and D. V. Goeddel, 1999. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421-429.
71. Tanji, C., H. Yamamoto, N. Yorioka, N. Kohno, K. Kikuchi, and A. Kikuchi. 2002. A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3β (GSK-3β) and mediates protein kinase A-dependent inhibition of GSK-3β. J. Biol. Chem. 277:36955-36961.
72. Thomas, G. M., S. Frame, M. Goedert, I. Nathke, P. Polakis, and P. Cohen. 1999. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett. 458:247-251.
73. Thomas, L. B., D. J. Gates, E. K. Richfield, T. F. O'Brien J. B. Sehweitzer, and D. A. Stethdler. 1995. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133:265-272.
74. Thompson, K. A., J. C. McArthur, and S. L. Wesselingh. 2001. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 49:745-752.
75. Tibbles, L. A., J. C. Spurrell, G. P. Bowen, Q. Liu, M. Lam, A. K. Zaiss, S. M. Robhins, M. D. Hollenherg, T. J. Wickham, and D. A. Muruve. 2002. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 76:1559-1568.
76. Tong, N., J. F. Sanchez, S. B. Maggirwar, S. H. Ramirez, H. Guo, S. Dew-hurst, and H. A. Gelhard. 2001. Activation of glycogen synthase kinase 3 beta (GSK-3β) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur. J. Neurosci. 13:1913-1922.
77. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerie. 1995. Phosphorylation of human 1 kappa B-alpha on serines 32 and 36 controls 1 kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:2876-2883.
78. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 274:787-789.
79. van Weeren, P. C., K. M. de Bruyn, A. M. de Vries-Smits, J. van Lint, and B. M. Burgering. 1998. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273:13150-13186.
80. von Knethen, A., D. Callsen, and B. Brune. 1999. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J. Immunol. 163:2858-2866.
81. Wachtel, M., M. F. Bolliger, H. Ishihara, K. Frei, H. Bluethmann, and S. M. Gloor. 2001. Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-κB activation. J. Neurochem. 78:155-162.
82. Wang, Q. M., C. J. Fiol, A. A. DePaoli-Roach, and P. J. Roach. 1994. Glycogen synthase kinase-3 heta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269:14566-14574.
83. Wad, L. D., and A. Richmond. 1995. Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors. J. Biol. Chem. 270:30619-30626.
84. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-beta: NF-κB activation and complex formation with IκB kinase-alpha and NIK. Science 278:866-869.
85. Yamamoto, Y., D. W. Kim, Y. T. Kwak, S. Prajapati, U. Verma and R. B. Gaynor. 2001, IKKγ/ANEMO facililates the recruitment of the IκB proteins into the IκB kinase complex. J. Biol. Chem. 276:36327-36336.
86. Yamaoka, S., G. Courtois, C. Bessia, S. T. Whiteside, R. Weil, F. Agou, H. E. Kirk, R. J. Kay, and A. Israel. 1998. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93:1231-1240.
87. Yost, C., M. Torres, J. R. Miller, E. Huang, D. Kimelman, and R. T. Moon. 1996. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1443-1454.
88. Zamanian-Daryoush, M., T. H. Mogensen, J. A. DiDonalo, and B. R. Williams. 2000. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20:1278-1290.